This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwebke, J. R.
Right arrow Articles by Burgess, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwebke, J. R.
Right arrow Articles by Burgess, D.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, October 2004, p. 794-803, Vol. 17, No. 4
0893-8512/04/$08.00+0     DOI: 10.1128/CMR.17.4.794-803.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Trichomoniasis

Jane R. Schwebke1* and Donald Burgess2

Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama,1 Department of Protistology, American Type Culture Collection, Manassas, Virginia2

Trichomoniasis is perhaps the most common curable sexually transmitted disease worldwide, yet few resources are devoted to its control. It is associated with potentially serious complications such as preterm birth and human immunodeficiency virus acquisition and transmission. The immunology of a related organism, Tritrichomonas foetus, which causes disease in cattle, has been investigated to some extent, but more work is needed for the human strain, Trichomonas vaginalis. In addition, although trichomoniasis is easily treated with oral metronidazole, there is concern that the number of strains resistant to this antibiotic are increasing, and currently no alternative is licensed in the United States. As more is appreciated concerning the important public health implications of this common infection, more work will need to be done in understanding the diagnosis, treatment, and immunology of this organism.


* Corresponding author. Mailing address: Department of Medicine, Division of Infectious Diseases, 703 19th St. South, Zeigler Research Bldg. no. 239, Birmingham, AL 35294-0007. Phone: (205) 975-5665. Fax: (205) 975-7764. E-mail: Schwebke{at}uab.edu.


Clinical Microbiology Reviews, October 2004, p. 794-803, Vol. 17, No. 4
0893-8512/04/$08.00+0     DOI: 10.1128/CMR.17.4.794-803.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Pal, D., Banerjee, S., Cui, J., Schwartz, A., Ghosh, S. K., Samuelson, J. (2009). Giardia, Entamoeba, and Trichomonas Enzymes Activate Metronidazole (Nitroreductases) and Inactivate Metronidazole (Nitroimidazole Reductases). Antimicrob. Agents Chemother. 53: 458-464 [Abstract] [Full Text]  
  • Shafir, S. C., Sorvillo, F. J., Smith, L. (2009). Current Issues and Considerations Regarding Trichomoniasis and Human Immunodeficiency Virus in African-Americans. Clin. Microbiol. Rev. 22: 37-45 [Abstract] [Full Text]  
  • Sansom, F. M., Robson, S. C., Hartland, E. L. (2008). Possible Effects of Microbial Ecto-Nucleoside Triphosphate Diphosphohydrolases on Host-Pathogen Interactions. Microbiol. Mol. Biol. Rev. 72: 765-781 [Abstract] [Full Text]  
  • Chen, K., Meng, Q., Ma, L., Liu, Q., Tang, P., Chiu, C., Hu, S., Yu, J. (2008). A novel DNA sequence periodicity decodes nucleosome positioning. Nucleic Acids Res 36: 6228-6236 [Abstract] [Full Text]  
  • Campbell, L., Woods, V., Lloyd, T., Elsayed, S., Church, D. L. (2008). Evaluation of the OSOM Trichomonas Rapid Test versus Wet Preparation Examination for Detection of Trichomonas vaginalis Vaginitis in Specimens from Women with a Low Prevalence of Infection. J. Clin. Microbiol. 46: 3467-3469 [Abstract] [Full Text]  
  • Munson, E., Napierala, M., Olson, R., Endes, T., Block, T., Hryciuk, J. E., Schell, R. F. (2008). Impact of Trichomonas vaginalis Transcription-Mediated Amplification-Based Analyte-Specific-Reagent Testing in a Metropolitan Setting of High Sexually Transmitted Disease Prevalence. J. Clin. Microbiol. 46: 3368-3374 [Abstract] [Full Text]  
  • Petropolis, D. B., Fernandes Rodrigues, J. C., da Rocha-Azevedo, B., Silva-Filho, F. C. e (2008). The binding of Tritrichomonas foetus to immobilized laminin-1 and its role in the cytotoxicity exerted by the parasite. Microbiology 154: 2283-2290 [Abstract] [Full Text]  
  • Grabinska, K. A., Ghosh, S. K., Guan, Z., Cui, J., Raetz, C. R. H., Robbins, P. W., Samuelson, J. (2008). Dolichyl-Phosphate-Glucose Is Used To Make O-Glycans on Glycoproteins of Trichomonas vaginalis. Eukaryot Cell 7: 1344-1351 [Abstract] [Full Text]  
  • Josey, W E, Schwebke, J R (2008). The polymicrobial hypothesis of bacterial vaginosis causation: a reassessment. Int J STD AIDS 19: 152-154 [Abstract] [Full Text]  
  • Simpson, P., Higgins, G., Qiao, M., Waddell, R., Kok, T. (2007). Real-time PCRs for detection of Trichomonas vaginalis {beta}-tubulin and 18S rRNA genes in female genital specimens. J Med Microbiol 56: 772-777 [Abstract] [Full Text]  
  • Ali, V., Nozaki, T. (2007). Current Therapeutics, Their Problems, and Sulfur-Containing-Amino-Acid Metabolism as a Novel Target against Infections by "Amitochondriate" Protozoan Parasites. Clin. Microbiol. Rev. 20: 164-187 [Abstract] [Full Text]  
  • Fichorova, R. N., Trifonova, R. T., Gilbert, R. O., Costello, C. E., Hayes, G. R., Lucas, J. J., Singh, B. N. (2006). Trichomonas vaginalis Lipophosphoglycan Triggers a Selective Upregulation of Cytokines by Human Female Reproductive Tract Epithelial Cells.. Infect. Immun. 74: 5773-5779 [Abstract] [Full Text]  
  • Madkan, V. K., Giancola, A. A., Sra, K. K., Tyring, S. K. (2006). Sex differences in the transmission, prevention, and disease manifestations of sexually transmitted diseases.. Arch Dermatol 142: 365-370 [Abstract] [Full Text]